Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review

The aim of this study was to assess the treatment patterns and safety of sunitinib, sorafenib and bevacizumab in real-world clinical settings in US, Europe and Asia. Medical records were abstracted at 18 community oncology clinics in the US and at 21 tertiary oncology centers in US, Europe and Asia...

Descripción completa

Detalles Bibliográficos
Autores principales: OH, WILLIAM K., McDERMOTT, DAVID, PORTA, CAMILLO, LEVY, ANTONIN, ELAIDI, REZA, SCOTTE, FLORIAN, HAWKINS, ROBERT, CASTELLANO, DANIEL, BELLMUNT, JOAQUIM, RHA, SUN YOUNG, SUN, JONG-MU, NATHAN, PAUL, FEINBERG, BRUCE A., SCOTT, JEFFREY, McDERMOTT, RAY, AHN, JIN-HEE, WAGSTAFF, JOHN, CHANG, YEN-HWA, OU, YEN-CHUAN, DONNELLAN, PAUL, HUANG, CHAO-YUAN, McCAFFREY, JOHN, CHIANG, PO-HUI, CHUANG, CHENG-KENG, KORVES, CAROLINE, NEARY, MAUREEN P., DIAZ, JOSE R., MEHMUD, FAISAL, DUH, MEI SHENG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867384/
https://www.ncbi.nlm.nih.gov/pubmed/24247547
http://dx.doi.org/10.3892/ijo.2013.2181

Ejemplares similares

Ejemplares similares